You have 9 free searches left this month | for more free features.

tocilizumab

Showing 1 - 25 of 243

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)

Recruiting
  • Tocilizumab
  • Thyroid Associated Ophthalmopathy
  • Tocilizumab
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 11, 2023

Sickle Cell Disease, Acute Chest Syndrome Trial (Tocilizumab)

Not yet recruiting
  • Sickle Cell Disease
  • Acute Chest Syndrome
  • Tocilizumab
  • (no location specified)
Nov 28, 2022

Malignant Pleural Effusion, Malignant Ascites Trial in Pittsburgh (Tocilizumab)

Not yet recruiting
  • Malignant Pleural Effusion
  • Malignant Ascites
  • Tocilizumab
  • Pittsburgh, Pennsylvania
    Allegheny Health Network Cancer Institute
Aug 30, 2023

Aneurysm, Behcet Syndrome, Vascular Type Trial in Beijing (tocilizumab, tofacitinib, cyclophosphamide)

Not yet recruiting
  • Aneurysm
  • Behcet Syndrome, Vascular Type
  • tocilizumab
  • +2 more
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 26, 2023

Behcet's Uveitis Trial (Adalimumab, Tocilizumab)

Not yet recruiting
  • Behcet's Uveitis
  • (no location specified)
May 15, 2023

Multiple Myeloma Trial in Suzhou (Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Tocilizumab
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
May 3, 2023

A Time to Cardiovascular Event Analysis Comparing Tocilizumab to

Completed
  • Rheumatoid Arthritis
  • Other Biologics
  • Tocilizumab
  • (no location specified)
Jan 20, 2023

Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

Active, not recruiting
  • Hematologic Malignancy
  • Milwaukee, Wisconsin
    Froedtert Hospital
Jan 31, 2023

Tocilizumab Versus Tocilizumab/Infliximab in COVID-19-associated

Completed
  • Covid19
  • +2 more
  • Cairo, Please Select, Egypt
    Teachers Hospital
Jul 19, 2022

Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Carmel, Indiana
  • +2 more
Apr 27, 2023

Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Tocilizumab
  • Nantes, France
    CHU of Nantes
Dec 16, 2022

COVID-19 Trial in Chicago (Tocilizumab, Standard of Care)

Recruiting
  • COVID-19
  • Tocilizumab
  • Standard of Care
  • Chicago, Illinois
    University of Chicago Medicine
May 11, 2022

Breast Cancer Trial in Fayoum (Tocilizumab, traditional Covid -19 therapy)

Completed
  • Breast Cancer
  • Tocilizumab
  • traditional Covid -19 therapy
  • Fayoum, Egypt
    ALsafwa specialized hospital
Oct 31, 2022

COVID-19 Trial in Chicago (Tocilizumab)

Completed
  • COVID-19
  • Tocilizumab
  • Chicago, Illinois
    University of Chicago Medicine
May 13, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 24, 2023

Juvenile Idiopathic Arthritis Trial (Upadacitinib, Tocilizumab)

Not yet recruiting
  • Juvenile Idiopathic Arthritis
  • (no location specified)
Nov 7, 2022

Coronary Artery Disease, Aortic Valve Disease Trial in Copenhagen (Tocilizumab, Isotonic sodium chloride (0.9%), Dexamethasone

Recruiting
  • Coronary Artery Disease
  • Aortic Valve Disease
  • Tocilizumab
  • +8 more
  • Copenhagen, Denmark
    The Heart Centre, Rigshospitalet
Nov 29, 2022

Lung Transplant Trial in Canada, United States (Tocilizumab, Placebo for Tocilizumab)

Not yet recruiting
  • Lung Transplant
  • Tocilizumab
  • Placebo for Tocilizumab
  • Phoenix, Arizona
  • +16 more
Sep 8, 2023

COVID-19 Trial in Patras (Tocilizumab, Baricitinib)

Recruiting
  • COVID-19
  • Patras, Greece
    University Hospital of Patras, Department of Respiratory Medicin
Apr 5, 2022

Hemophagocytic Lymphohistiocytosis Trial in Philadelphia (tocilizumab)

Withdrawn
  • Hemophagocytic Lymphohistiocytosis
  • tocilizumab
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Mar 11, 2022

Coronavirus Infection, SARS (Severe Acute Respiratory Syndrome), Virus Diseases Trial in Cayenne (Tocilizumab, Dexamethasone)

Completed
  • Coronavirus Infection
  • +7 more
  • Cayenne, French Guiana
    CH Andrée Rosemon
Jun 7, 2022

Pancreatic Cancer Trial in Herlev (Nivolumab, Ipilimumab, Tocilizumab)

Terminated
  • Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Mar 15, 2022

COVID-19 Severe Respiratory Failure Trial in Alexandroupolis (Dexamethasone, Low molecular weight heparin, Anakinra 100Mg/0.67Ml

Recruiting
  • COVID-19 Severe Respiratory Failure
  • Alexandroupolis, Evros, Greece
    University Hospital of Alexandroupolis
Mar 11, 2022

COVID-19 Trial in New York (Tocilizumab)

Active, not recruiting
  • COVID-19
  • Tocilizumab
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 2, 2022